Skip to main content
padlock icon - secure page this page is secure

Near Infrared Visible Biocompatible Particles Maintain Optical Signal in Dystrophic Muscle

Buy Article:

$105.00 + tax (Refund Policy)

Background: Near Infrared (NIR) active biocompatible particles have great potential to aid in the understanding of the delivery of therapeutic agents in the muscular dystrophies. Currently, tracking of such particles remains primarily performed through ex vivo analysis. The combination of clinically used compounds, such as indocyanine green (ICG) and poly-lactic acid (PLA), to compose NIR active particles that can be tracked in vivo could serve this need. Methods: ICG was encapsulated in PLA based particles and optical stability was assessed both in aqueous solution and in vivo. ICG-PLA particles were delivered subcutaneously and intramuscularly into the hindlimbs of control and dystrophic mice. Results: ICG-PLA particles (205±78 nm) were produced and demonstrated fluorescence properties similar to aqueous ICG. ICG-PLA particles had a half-life up to 82 fold greater than that of aqueous ICG in vitro. Similarly, ICG loaded particles demonstrated prolonged fluorescence for up to four weeks following intramuscular injections into dystrophic mice, whereas aqueous ICG fluorescence was extinguished 15 times quicker, returning to baseline fluorescence levels within one week. Conclusion: ICG-PLA biocompatible particles have increased stability and permit prolonged optical imaging in dystrophic muscle. This NIR platform has the potential to track particle distribution in vivo in a reliable, longitudinal safe, inexpensive, non-invasive, and facile manner.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: DUCHENNE MUSCULAR DYSTROPHY; INDOCYANINE GREEN; MDX MOUSE; MUSCLE DAMAGE; NEAR INFRARED OPTICAL IMAGING; POLY LACTIC ACID

Document Type: Research Article

Publication date: 01 May 2017

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more